NOMAD POWER SOLUTIONS, INC. Proceeds from Issuance of Warrants
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Proceeds from Issuance of Warrants of $41 for the 9-month period ending 2023-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2024-11-12
- NOMAD POWER SOLUTIONS, INC. proceeds from issuance of warrants for the quarter ending 2021-12-31 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from issuance of warrants for the quarter ending 2021-09-30 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from issuance of warrants for the quarter ending 2021-06-30 was $0.00.
- NOMAD POWER SOLUTIONS, INC. proceeds from issuance of warrants for the quarter ending 2021-03-31 was $17.10K.
- NOMAD POWER SOLUTIONS, INC. proceeds from issuance of warrants for fiscal 2021 was $17.10K.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|
| 2023-09-30 | $41.00 10-Q · filed 2024-11-12 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | $0.00 derived: sum of 3 quarters · filed 2022-03-21 | $17.10K 10-K · filed 2022-03-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $17.10K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $17.10K 10-Q · filed 2021-08-10 | ||
| 2021-03-31 | $17.10K 10-Q · filed 2021-05-12 | |||
| 2012-09-30 | $3.00M 10-Q · filed 2013-05-09 | $6.00M derived: sum of 2 quarters · filed 2013-05-09 | ||
| 2012-06-30 | $3.00M 10-Q · filed 2012-08-10 | $3.00M 10-Q · filed 2013-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |